Migraine crisis in Catalonia is a silent epidemic affecting over a million people, according to a new report. The condition, often dismissed as a simple headache, is a complex neurological disorder that sees specialist hospital units overwhelmed by a 38% surge in demand.

Migraine Crisis in Catalonia: A Silent Epidemic The scale of the problem is immense.

Your browser does not support the video tag.

More than 1.1 billion people worldwide live with a primary headache disorder. In Catalonia, that translates to nearly one million affected individuals. However, the Unitat de Cefalees at Barcelona’s Hospital Clínic, a key reference centre, has seen first visits jump from 955 in 2021 to 1,321 in 2022. Meanwhile, this isn’t necessarily more patients, experts say.

“Migraine is a hereditary disease,” insists Dr Robert Belvis, coordinator of the Headache Group of the Spanish Society of Neurology. Recent genetic studies back this up, identifying dozens of DNA variants that create a baseline of vulnerability. However, the brain of a migraine sufferer is wired differently from birth, predisposed to hyperexcitability.

However, a major therapeutic revolution is underway. Dr Patricia Pozo Rosich, President of the International Headache Society, outlines three key stages. However, the 1990s brought triptans, the first drugs designed to stop an acute attack. Meanwhile, then came botulinum toxin as a preventive treatment for chronic migraine. Additionally, the current revolution, she says, changes everything. “These new drugs are a hugely important advance because we haven’t repurposed any existing medication,” Pozo explains.

Migraine Crisis In Catalonia: Key Details

The Paradox of Modern Treatment and Systemic Failure The breakthrough came from identifying a key pain messenger molecule called CGRP. New drugs act as molecular snipers to neutralise this pathway. They include injectable monoclonal antibodies and a new class of oral drugs called gepants.

But here lies a crucial paradox. “They respond much better in patients with less frequent migraine,” she warns. However, this scientific finding is a sentence that focuses on the system’s great failure: arriving late has biological consequences. Meanwhile, “Patients arrive late to the neurologist,” alerts Dr Belvis.

This lost time has a terrible biological cost. Constant pain signals cause the central nervous system to “learn” to feel pain more efficiently-a phenomenon called central sensitisation. Neurons lower their activation threshold, and the brain begins to interpret non-painful stimuli, like the touch of hair, as painful.

The chain of delays is built on deep stigma. “Migraine is the most stigmatised disease, very close to schizophrenia,” states Dr Pozo. This perception is fed by a lack of objective biomarkers, making it seem socially like “not a real biological disease.” This invisibility is costly.

The solution, therefore, is no longer just in the lab. Research is already looking beyond CGRP, exploring alternative pain pathways. But for a systemic problem, the solution cannot be only pharmacological. “What we need is a state strategic plan against migraine,” demands Dr Belvis. In Catalonia, this would mean providing more resources to specialised units and ensuring protocols reach all primary care centres.

Science has begun to map the pain. Now society must learn to read it. However, the stories of over a million Catalans create an urgency that should finally focus on the real suffering behind a word too small for such immense pain.

Impact and Response

Stay connected with us on social media for the latest updates and news!
TikTok | Instagram | YouTube | X.

Source: Read original article.

.